Correlation Between Akums Drugs and Cambridge Technology

Can any of the company-specific risk be diversified away by investing in both Akums Drugs and Cambridge Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akums Drugs and Cambridge Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akums Drugs and and Cambridge Technology Enterprises, you can compare the effects of market volatilities on Akums Drugs and Cambridge Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akums Drugs with a short position of Cambridge Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akums Drugs and Cambridge Technology.

Diversification Opportunities for Akums Drugs and Cambridge Technology

0.26

Correlation Coefficient

Akums Drugs  Cambridge Technology

Modest diversification

The 3 months correlation between Akums and Cambridge is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Akums Drugs and and Cambridge Technology Enterpris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cambridge Technology and Akums Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akums Drugs and are associated (or correlated) with Cambridge Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cambridge Technology has no effect on the direction of Akums Drugs i.e., Akums Drugs and Cambridge Technology go up and down completely randomly.

Pair Corralation between Akums Drugs and Cambridge Technology

Assuming the 90 days trading horizon Akums Drugs and is expected to under-perform the Cambridge Technology. But the stock apears to be less risky and, when comparing its historical volatility, Akums Drugs and is 1.03 times less risky than Cambridge Technology. The stock trades about -0.09 of its potential returns per unit of risk. The Cambridge Technology Enterprises is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  5,770  in Cambridge Technology Enterprises on September 20, 2024 and sell it today you would earn a total of  4,954  from holding Cambridge Technology Enterprises or generate 85.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	19.26%
Values	Daily Returns

Akums Drugs and  vs.  Cambridge Technology Enterpris

Akums Drugs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Cambridge Technology

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cambridge Technology Enterprises are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, Cambridge Technology may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Akums Drugs and Cambridge Technology

The main advantage of trading using opposite Akums Drugs and Cambridge Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akums Drugs position performs unexpectedly, Cambridge Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cambridge Technology will offset losses from the drop in Cambridge Technology's long position.

The idea behind Akums Drugs and and Cambridge Technology Enterprises pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.